Insider Cluster (2 insiders) ·Filed Jul 11, 2026

APGE

Apogee Therapeutics, Inc.
NEUTRAL
Impact 2/10
Horizondays Processed2mo ago
Insider cluster: 2 insiders, $3.4M total
Actionable Insight • Neutral

Cluster sales are too small to read as bearish — treat as routine portfolio diversification. Monitor for any acceleration in insider selling volume in coming weeks.

DirectionNeutral
Confidencehigh
Horizondays
Latest settled — T+20d
APGE ▲ +0.62% at T+20d
NEUTRAL call ✓ call won +0.62% · α vs SPY -2.56% · entry $133.82 → $134.65
Next anchor: T+60d in 3d
Entry anchored
Jul 10, 2026
via day open
T+1d
+0.10%
call +0.10% · α -0.25%
$133.96
settled 3mo ago
T+5d
+0.13%
call +0.13% · α +0.92%
$134.00
settled 3mo ago
T+20d
+0.62%
call +0.62% · α -2.56%
$134.65
settled 8w ago
T+60d
—
call — · α —
—
in 3d

Price Chart

Loading chart...

Executive Summary

CEO Michael Thomas Henderson sold $2.67M and CMO Carl Dambkowski sold $730K of APGE shares in a small cluster. Combined sales of $3.4M represent just 0.034% of the $10.1B market cap — a trivial amount with no material signal.

Key Financial Metrics

Direction
selling
Total Value
$3.4M
Insiders
2

Key Facts

  • CEO sold 20,000 shares at $133.63 for $2.67M on 2026-07-08
  • CMO sold 5,500 shares at $132.74 for $730K on 2026-07-01
  • Total cluster value $3.4M, only 0.034% of $10.1B market cap
  • CEO also gifted 75,046 shares (non-cash transfer) on 2026-07-10

Financial Impact

Insider sales of $3.4M, negligible relative to $10.1B market cap

dilution (none)

Risk Factors

  • Potential future selling if executives continue to reduce positions
  • No immediate risk from current cluster

Market Snapshot

Exchange
Nasdaq
Sector
Biological Products, (No Diagnostic Substances)
Analyst Consensus
33% bullish (21 analysts)

Investment Themes

Biotech & Drug Discovery

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-APGE-1783728044958
31 reports for APGE
Performance horizon
93% Hit rate 14 of 15 directional calls best @ T+60▲ +73.31%May 27, 2026
Filters
Rows
Reports for APGE — sortable, filterable
TypeNow
Sep 14, 2026
18d ago
15-12G
NEUTRAL ★ 4/10
—awaiting T+5——
Sep 3, 2026
29d ago
25-NSE
BULLISH ★ 8/10
$135.06 awaiting T+5awaiting T+5——
Sep 3, 2026
29d ago
8-K
BULLISH ★ 8/10
$135.06 awaiting T+5awaiting T+5——
Aug 11, 2026
7w ago
8-K
BULLISH ★ 7/10
$134.55 $134.71▲ +0.12%▲ +0.56%—
Aug 10, 2026
7w ago
8-K
BULLISH ★ 8/10
$134.65 $134.59▼ −0.04%▲ +0.00%—
Aug 10, 2026
7w ago
Press Release
BULLISH ★ 8/10
$134.65 $134.59▼ −0.04%▲ +0.00%—
Aug 6, 2026
8w ago
Institutional Cluster
MIXED ★ 5/10
$134.49 $134.45▼ −0.03%▼ −1.24%—
Aug 3, 2026
8w ago
DEFA14A
BULLISH ★ 5/10
$134.19 $134.69▲ +0.37%▲ +0.47%—
Jul 11, 2026
11w ago
Insider Cluster
NEUTRAL ★ 2/10
$133.82 $134.00▲ +0.13%▲ +0.92%—
Jun 26, 2026
13w ago
DEFA14A
BULLISH ★ 6/10
$132.61 $133.50▲ +0.67%▼ −0.72%—
Showing 10 of 31

US Market Status

Market Open — Closes in 32m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access
Report published Jul 11, 2026